All Stories

  1. How Much Vitamin D is Too Much? A Case Report and Review of the Literature
  2. Lessons Learned in Andrology: Back to the future: making children in bed (at the right time)
  3. The PCOS evolutionary paradox: a GWAS-based, in silico, evolutionary explanation
  4. GH Deficiency in HIV-infected patients compared to hypopituitary patients
  5. The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro
  6. Gonadal and sexual function in young/middle aged human immunodeficiency virus (HIV)-infected men
  7. TERT promoter mutations correlate with a more advanced stage at diagnosis and with a poorer prognosis in differentiated thyroid cancer
  8. Reassembly of somatic cells and testicular organogenesis in vitro
  9. Gene Polymorphisms in Female Reproduction
  10. MECHANISMS IN ENDOCRINOLOGY: Genetics of FSH action: a 2014-and-beyond view
  11. Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer?
  12. The Diagnostic Value of Calcitonin Measurement in Wash-Out Fluid from Fine-Needle Aspiration of Thyroid Nodules in the Diagnosis of Medullary Thyroid Cancer
  13. The prognostic value of miRNA146a in follicular thyroid carcinoma
  14. Effects of treatment for acromegaly on bone mineral density: is pegvisomant protective on lumbar BMD?
  15. Pre-miR146a expression profiling of follicular thyroid carcinoma
  16. Genotype and phenotype characterization of the cohort of Italian patients with idiopathic central hypogonadism (ICH)
  17. The combination of genetic variants in the FSHR and FSHB genes affect serum FSH in women of reproductive age
  18. Association of pre-miR-146a rs2910164 GG genotype with papillary thyroid cancer: a new case--control study on two adjacent genes on chromosome 5, pre-miR-146a and PTTG1.
  19. Mutations and somatic changes in the genotype of rs2910164 in pre-miR146a are frequent in follicular thyroid carcinoma
  20. Complete aromatase deficiency in four adult men: detection of a novel mutation and two known mutations in theCYP19A1gene
  21. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization
  22. Prevalence of Olfactory and Other Developmental Anomalies in Patients with Central Hypogonadotropic Hypogonadism
  23. LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling
  24. Aromatase expression in human peripheral blood leucocytes (PBLs) and in various tissues in primates: studies in elderly humans and cynomolgus monkeys
  25. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R−/−) mice
  26. Methodology for measuring testosterone, dihydrotestosterone and sex hormone-binding globulin in a clinical setting
  27. Testosterone-Induced Prostate Growth Is Blocked by Co- and Preadministration of Norethisterone Enanthate in Castrated Cynomolgus Monkeys
  28. Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function
  29. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells
  30. Copy Number Variants in Patients with Severe Oligozoospermia and Sertoli-Cell-Only Syndrome
  31. Pharmacogenetics of ovarian stimulation in the twenty-first century
  32. Genetic screening for infertility: When should it be done?
  33. Male 41, XXY* Mice as a Model for Klinefelter Syndrome: Hyperactivation of Leydig Cells
  34. Endocrine Laboratory Diagnosis
  35. Cytogenetic and Molecular Genetic Investigations
  36. Physiology of Testicular Function
  37. Diseases of the Hypothalamus and the Pituitary Gland
  38. Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes
  39. Endokrine Labordiagnostik
  40. Zytogenetische und molekulargenetische Untersuchungen
  41. Physiologie der Hodenfunktion
  42. Störungen im Bereich des Hypothalamus und der Hypophyse
  43. Impaired recognition memory in male mice with a supernumerary X chromosome
  44. Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause
  45. Mutations in a Novel, Cryptic Exon of the Luteinizing Hormone/Chorionic Gonadotropin Receptor Gene Cause Male Pseudohermaphroditism
  46. Complete Spermatogenesis in Orthotopic But Not in Ectopic Transplants of Autologously Grafted Marmoset Testicular Tissue
  47. Krüppel-like factor 4 is involved in functional differentiation of testicular Sertoli cells
  48. Polymorphisms of the luteinizing hormone/chorionic gonadotropin receptor gene: association with maldescended testes and male infertility
  49. Clinical consequences of microdeletions of the Y chromosome: the extended Münster experience
  50. LHR splicing variants and gene expression in the marmoset monkey
  51. Chorionic Gonadotropin β-Subunit Gene Expression in the Marmoset Pituitary Is Controlled by Steroidogenic Factor 1, Early Growth Response Protein 1, and Pituitary Homeobox Factor 1
  52. Genomic Checkpoints for Exon 10 Usage in the Luteinizing Hormone Receptor Type 1 and Type 2
  53. Replacement of connexin43 by connexin26 in transgenic mice leads to dysfunctional reproductive organs and slowed ventricular conduction in the heart
  54. Genetics of Hypogonadotropic Hypogonadism
  55. Gene polymorphisms and male infertility – a meta-analysis and literature review
  56. Elevated follicle-stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue
  57. Hypothalamic and Gonadal Components of Hypogonadism in Boys with Prader-Labhart- Willi Syndrome
  58. Endogenous Progesterone and the Exogenous Progestin Norethisterone Enanthate Are Associated with a Proinflammatory Profile in Healthy Men
  59. Genetic complexity of FSH receptor function
  60. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor
  61. Pharmacokinetics and pharmacodynamics of injectable testosterone undecanoate in castrated cynomolgus monkeys (Macaca fascicularis) are independent of different oil vehicles
  62. Pharmacogenetics in ovarian stimulation – current concepts and future options
  63. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy
  64. Gene expression profiling of mouse Sertoli cell lines
  65. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility
  66. Absence of Exon 10 of the Human Luteinizing Hormone (LH) Receptor Impairs LH, But Not Human Chorionic Gonadotropin Action
  67. An Activated Human Follicle-Stimulating Hormone (FSH) Receptor Stimulates FSH-Like Activity in Gonadotropin-Deficient Transgenic Mice
  68. CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception
  69. Association of basal follicle stimulating hormone (FSH) levels with FSH receptor variants in subfertile women with normal menstrual cycle: implications for ovarian sensitivity to FSH
  70. Inverse Correlation between Sperm Concentration and Number of Androgen Receptor CAG Repeats in Normal Men1
  71. Follicle-stimulating-hormone receptor and twinning
  72. Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype1
  73. Male Hypogonadism Caused by Homozygous Deletion of Exon 10 of the Luteinizing Hormone (LH) Receptor: Differential Action of Human Chorionic Gonadotropin and LH
  74. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men
  75. Constitutively Active Mutations of G Protein-Coupled Receptors
  76. Cloning and expression of cynomolgus monkey (Macaca fascicularis) gonadotropins luteinizing hormone and follicle-stimulating hormone and identification of two polymorphic sites in the luteinizing hormone β subunit
  77. Clinical Trial of Transdermal Testosterone and Oral Levonorgestrel for Male Contraception1
  78. Mutational Analysis of the Follicle-Stimulating Hormone (FSH) Receptor in Normal and Infertile Men: Identification and Characterization of Two Discrete FSH Receptor Isoforms1
  79. The EAA International Quality Control Programme for Y‐Chromosomal Microdeletions
  80. Molecular Pathophysiology and Clinical Manifestations of Gonadotropin Receptor Defects
  81. A Mutation in the First Transmembrane Domain of the Lutropin Receptor Causes Male Precocious Puberty
  82. The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology1
  83. Strong association between serum levels of leptin and testosterone in men
  84. Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency
  85. Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia
  86. Functional and clinical consequences of mutations in the FSH receptor
  87. FSH in therapy: physiological basis, new preparations and clinical use
  88. In Vitro Sertoli Cell Bioassay of Follicle-Stimulating Hormone (FSH): Serum from Different Animal Species Alters the Morphology of Rat Sertoli Cells without Affecting Their Response to FSH
  89. Transgenic animals in male reproduction research
  90. Molecular heterogeneity of serum follicle‐stimulating hormone in hypogonadal patients before and during androgen replacement therapy and in normal men
  91. Effects of antiandrogens and ethane dimethane sulphonate (EDS) on gene expression, free subunits, bioactivity and secretion of pituitary gonadotrophins in male rats
  92. Serum Bioactive Follicle-Stimulating Hormone-Like Activity in Human Pregnancy Is a Methodological Artifact*